×
Pulmonx Pre-Tax Profit Margin 2019-2024 | LUNG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Pulmonx pre-tax profit margin from 2019 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Historical Chart (TTM)
Quarterly
Annual
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$37.1B
Hims & Hers Health (HIMS)
$14.5B
Tempus AI (TEM)
$12.1B
Inspire Medical Systems (INSP)
$5.3B
IRhythm Technologies (IRTC)
$3.5B
Privia Health (PRVA)
$3B
Enovis (ENOV)
$2.5B
Clover Health Investments (CLOV)
$2.2B
Azenta (AZTA)
$2B
Omnicell (OMCL)
$1.8B
Schrodinger (SDGR)
$1.7B
Phreesia (PHR)
$1.7B
10x Genomics (TXG)
$1.4B
Butterfly Network (BFLY)
$944M
Talkspace (TALK)
$556M
Fulgent Genetics (FLGT)
$509M
Standard BioTools (LAB)
$503M
TruBridge (TBRG)
$417M
Nyxoah SA (NYXH)
$354M
Health Catalyst (HCAT)
$328M
SOPHiA GENETICS SA (SOPH)
$277M
American Well (AMWL)
$188M
EUDA Health Holdings (EUDA)
$101M
MDxHealth SA (MDXH)
$88M
P3 Health Partners (PIII)
$78M
111 (YI)
$70M
CareCloud (CCLD)
$61M
HeartBeam (BEAT)
$56M
Outset Medical (OM)
$52M
Zepp Health (ZEPP)
$45M